Plerixafor is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). This agent was approved on Dec. 15, 2008, as treatment in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize HSCs to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).

CAS：110078-46-1
中文别名：MOZOBIL PLERIXAFOR;
英文别名：Mozobil;Unii-S915p5499n;1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene;Sdz sid 791;
分子式：C28H54N8
分子量：502.782
精确质量：502.447
Psa：78.66
Logp：2.2644

MDL号：MFCD05662218

密度：0.962
沸点：657.5ºC at 760 mmHg
闪点：361.8ºC
蒸汽压：1.06E-34mmHg at 25°C

海关编码：2933990090